We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

58 hedge funds and large institutions have $28.2M invested in ProQR Therapeutics in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,387% more call options, than puts

Call options by funds: $1.67M | Put options by funds: $67K

13% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 16

22% less funds holding

Funds holding: 74 → 58 (-16)

26.34% less ownership

Funds ownership: 70.95% → 44.61% (-26%)

48% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 33

92% less capital invested

Capital invested by funds: $365M → $28.2M (-$337M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
58
Holders Change
-16
Holders Change %
-21.62%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
17
Increased
18
Reduced
16
Closed
33
Calls
$1.67M
Puts
$67K
Net Calls
+$1.6M
Net Calls Change
+$1.7M

Top Buyers

Rank Fund Capital Flow
1
MCM
M28 Capital Management
Connecticut
+$3.36M
2
OM
Opaleye Management
Massachusetts
+$3.31M
3
Two Sigma Investments
Two Sigma Investments
New York
+$2.49M
4
Renaissance Technologies
Renaissance Technologies
New York
+$2.02M
5
PFM
Privium Fund Management
Netherlands
+$1.6M

Top Sellers

Rank Fund Capital Flow
1
DCM
Driehaus Capital Management
Illinois
-$16M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$14.9M
3
Jennison Associates
Jennison Associates
New York
-$14.5M
4
Goldman Sachs
Goldman Sachs
New York
-$10.5M
5
GPP
Great Point Partners
Connecticut
-$8.98M
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
26
Monaco Asset Management
Monaco
$82K +$305K +90,900 New
AA
27
ALPS Advisors
Colorado
$67K -$28.6K -8,548 -10%
CM
28
Caption Management
Oklahoma
$55K +$201K +60,000 New
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$51K – – –
Squarepoint
30
Squarepoint
New York
$45K +$167K +49,878 New
AC
31
Apogem Capital
New York
$40K +$57K +17,025 +63%
Group One Trading
32
Group One Trading
Illinois
$38K -$26.6K -7,935 -16%
Mitsubishi UFJ Asset Management
33
Mitsubishi UFJ Asset Management
Japan
$36K +$8.14K +2,431 +7%
Geode Capital Management
34
Geode Capital Management
Massachusetts
$32K – – –
AI
35
Atom Investors
Texas
$28K +$102K +30,422 New
Jane Street
36
Jane Street
New York
$21K +$18.5K +5,515 +32%
Osaic Holdings
37
Osaic Holdings
Arizona
$20K +$1.21K +361 +2%
Barclays
38
Barclays
United Kingdom
$20K +$75.6K +22,580 +112,900%
Bank of America
39
Bank of America
North Carolina
$18K -$564K -168,335 -90%
Daiwa Securities Group
40
Daiwa Securities Group
Japan
$17K +$19.6K +5,860 +45%
CG
41
Cutler Group
California
$13K +$20.1K +6,010 +64%
CSS
42
Cubist Systematic Strategies
Connecticut
$13K +$45.9K +13,697 +1,948%
TSS
43
Two Sigma Securities
New York
$13K +$46.7K +13,941 New
BCM
44
Bayesian Capital Management
New York
$12K +$45.6K +13,600 New
JG
45
Jefferies Group
New York
$10.3K +$38.1K +11,375 New
Citigroup
46
Citigroup
New York
$10K -$15.4K -4,585 -29%
KAS
47
Kestra Advisory Services
Texas
$10K – – –
Wells Fargo
48
Wells Fargo
California
$10K – – –
AG
49
Algert Global
California
$10K +$37.9K +11,310 New
VPIM
50
Vanguard Personalized Indexing Management
California
$10K +$37.9K +11,312 New
1
2
3 4

PRQR Hedge Fund Activity: Q1 2022 in Review

58 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q1 2022, worth a combined $28.2M — down 92% from $365M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of PRQR and 17 opened new positions — a net loss of 16 holders — while 16 trimmed existing stakes and 18 added.

The largest buyer was M28 Capital Management, opening a new position worth an estimated $3.36M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $16M sold.

  • 58 institutional investors held ProQR Therapeutics (PRQR) as of Q1 2022, down from 74 in Q4 2021.
  • Funds reported $28.2M of ProQR Therapeutics stock for Q1 2022, down 92% quarter-over-quarter.
  • 17 funds opened new ProQR Therapeutics positions in Q1 2022 and 33 closed out, a net change of -16 holders.
  • The largest ProQR Therapeutics buyer in Q1 2022 was M28 Capital Management, an estimated $3.36M added.
  • The largest ProQR Therapeutics seller in Q1 2022 was Driehaus Capital Management, an estimated $16M sold.

Based on aggregated 13F filings for Q1 2022.